PROTOCOL_ID_OR_DOCUMENT_NUMBER	TITLE	PHASE	LEAD_ORGANIZATION_CTEP_ID_COLON_PRINCIPAL_INVESTIGATOR_NES_ID_SEMICOLON_DELIMITED	AGENTS_SEMICOLON_DELIMITED	INVESTIGATOR_NES_ID_SEMICOLON_DELIMITEDINC07-10-01	Sample Protocol	II/III	VA166:269510	Aspirin;Nyquil	MAY03-1-02	Randomized, Phase IIb Trial of Sulindac in Smokers with Bronchial Dysplasia	II	02018:269052	Sulindac	DEC05-25-21	A Test Protocol	IV		Glycerin;Aspirin;Tylenol	MAY03-1-02	Randomized, Phase IIb Trial of Sulindac in Smokers with Bronchial Dysplasia	II	02018:269052	Sulindac	zNuUUAQa9EHtr4rqHK1YFceDxucyGgJzrMLQrqdaXaHmIBfkUAocSguRoksZMUYPPlgJL4QejzcPyuDkvPkIpR2OkZdl70SVv6hbkBVxosBocC3Jm4CoUGT7R8Fd7Ylkbn2POfe9WGLdqns5GgbFJTaWqRzx6UN27vhP1K6kmbGPaEVQ5DNpzYHn1bsTMve1t2Y5u8J6r	Another Protocol as a test scenario	III		Sample Agent 1;Sample Agent 2;Sample Agent 3	NWU04-4-01	Phase IIb Trial of ADT in Subjects with Bronchial Dysplasia	II		Anethole Trithione	